biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by unclepiemanon Jun 24, 2014 11:38pm

292 Views

Post# 22691916

time to sell?

well... it looks like BTI has become just another story, nothing real came out of this. its upsetting since the technology was sound however, given the lack of real management the company has lost pretty must all of its interested parties; but one left that is testing.

any thoughts? id like to hear what others are planning on doing at this point,
Also, why would the CFO retire after such a long time? and why sign up with a firm that is running out of a basement?

no clue wtf is going on with bti anymore

Bullboard Posts

The top 10 Canadian medical stocks